LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC
LVAC was delisted on the 10th of May, 2023.
53 hedge funds and large institutions have $104M invested in LAVA Medtech Acquisition Corp. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 7 closing their positions.
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
10% more capital invested
Capital invested by funds: $94.6M → $104M (+$9.21M)
8% more funds holding
Funds holding: 49 → 53 (+4)
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
+$6.07M |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$2.61M |
| 3 |
CCM
Context Capital Management
Lajolla,
California
|
+$2.28M |
| 4 |
BI
Bulldog Investors
Saddle Brook,
New Jersey
|
+$542K |
| 5 |
EC
Elequin Capital
New York
|
+$506K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$2.88M |
| 2 |
JP Morgan Chase
New York
|
-$2.77M |
| 3 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$1.45M |
| 4 |
CM
Cohanzick Management
Pleasantville,
New York
|
-$517K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$230K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Barclays
London,
United Kingdom
| $6.11K | – | – | – |
|
52
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $5.87K | +$5.81K | +574 | New |
|
|
TRCT
53
Tower Research Capital (TRC)
New York
| $2K | -$1.19K | -118 | -37% |
|
|
UOC
54
UBS O'Connor
Chicago,
Illinois
| – | -$2.88M | -286,348 | Closed |
|
|
55
JP Morgan Chase
New York
| – | -$2.77M | -275,091 | Closed |
|
|
BCM
56
Basso Capital Management
Stamford,
Connecticut
| – | -$1.45M | -144,891 | Closed |
|
|
CM
57
Cohanzick Management
Pleasantville,
New York
| – | -$517K | -51,515 | Closed |
|
|
AA
58
Ancora Advisors
Cleveland,
Ohio
| – | -$34K | -3,409 | Closed |
|
59
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$21K | -2,062 | Closed |
|
LVAC Hedge Fund Activity: Q4 2022 in Review
53 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) for Q4 2022, worth a combined $104M — up 9.7% from $94.6M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new LVAC positions and 7 closed out — a net gain of 4 holders — while 2 added to existing stakes and 7 trimmed.
The largest buyer was Castle Creek Arbitrage, opening a new position worth an estimated $6.07M. The largest seller was UBS O'Connor, exiting entirely with an estimated $2.88M sold.
- 53 institutional investors held LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) as of Q4 2022, up from 49 in Q3 2022.
- Funds reported $104M of LAVA Medtech Acquisition Corp. Class A Common Stock stock for Q4 2022, up 9.7% quarter-over-quarter.
- 11 funds opened new LAVA Medtech Acquisition Corp. Class A Common Stock positions in Q4 2022 and 7 closed out, a net change of +4 holders.
- The largest LAVA Medtech Acquisition Corp. Class A Common Stock buyer in Q4 2022 was Castle Creek Arbitrage, an estimated $6.07M added.
- The largest LAVA Medtech Acquisition Corp. Class A Common Stock seller in Q4 2022 was UBS O'Connor, an estimated $2.88M sold.
Based on aggregated 13F filings for Q4 2022.